US Stock MarketDetailed Quotes
APYX Apyx Medical
- 1.450
- +0.010+0.69%
Close Nov 26 16:00 ET
- 1.450
- 0.0000.00%
Post 20:01 ET
54.58MMarket Cap-1768P/E (TTM)
1.480High1.390Low42.80KVolume1.440Open1.440Pre Close61.10KTurnover0.15%Turnover RatioLossP/E (Static)37.64MShares2.80052wk High4.95P/B41.94MFloat Cap0.96752wk Low--Dividend TTM28.92MShs Float17.500Historical High--Div YieldTTM6.25%Amplitude0.967Historical Low1.427Avg Price1Lot Size
Apyx Medical Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.08%11.49M | -10.47%12.15M | -15.63%10.24M | 17.61%52.35M | 16.26%14.66M | 31.40%11.98M | 31.84%13.57M | -2.81%12.14M | -8.26%44.51M | -25.04%12.61M |
| Operating revenue | -4.08%11.49M | -10.47%12.15M | -15.63%10.24M | 17.61%52.35M | 16.26%14.66M | 31.40%11.98M | 31.84%13.57M | -2.81%12.14M | -8.26%44.51M | -25.04%12.61M |
| Cost of revenue | 13.38%4.53M | 8.53%4.66M | -6.00%4.3M | 20.88%18.59M | 31.19%5.73M | 19.09%4M | 27.00%4.29M | 6.90%4.57M | 3.10%15.38M | -6.48%4.37M |
| Gross profit | -12.84%6.95M | -19.25%7.49M | -21.44%5.95M | 15.89%33.76M | 8.35%8.93M | 38.58%7.98M | 34.21%9.28M | -7.86%7.57M | -13.30%29.13M | -32.18%8.24M |
| Operating expense | -16.06%10.59M | -1.26%13.04M | -4.70%12.56M | 1.93%53.71M | 3.75%14.71M | 9.32%12.62M | 2.45%13.21M | -6.43%13.18M | 9.67%52.69M | 2.39%14.17M |
| Selling and administrative expenses | -15.70%9.45M | -1.97%11.62M | -6.26%11.17M | 1.49%48.87M | 7.58%13.9M | 6.95%11.21M | 0.25%11.85M | -7.88%11.91M | 10.11%48.15M | 0.18%12.92M |
| -General and administrative expense | -15.70%9.45M | -1.97%11.62M | -6.26%11.17M | 1.49%48.87M | 7.58%13.9M | 6.95%11.21M | 0.25%11.85M | -7.88%11.91M | 10.11%48.15M | 0.18%12.92M |
| Research and development costs | -18.95%1.14M | 4.94%1.42M | 9.91%1.4M | 6.60%4.84M | -35.70%807K | 32.80%1.41M | 26.82%1.36M | 9.76%1.27M | 5.16%4.54M | 32.52%1.26M |
| Operating profit | 21.61%-3.64M | -41.25%-5.55M | -17.89%-6.62M | 15.33%-19.95M | 2.65%-5.78M | 19.80%-4.64M | 34.29%-3.93M | 4.43%-5.61M | -63.08%-23.56M | -250.65%-5.93M |
| Net non-operating interest income expense | -212.46%-1.05M | -171.43%-988K | -392.35%-901K | -1,196.48%-1.56M | -1,203.28%-673K | -568.06%-337K | -2,526.67%-364K | -2,950.00%-183K | 14,100.00%142K | 6,000.00%61K |
| Non-operating interest income | 52.42%378K | 145.25%439K | 870.59%495K | 486.62%921K | 592.19%443K | 239.73%248K | 894.44%179K | 2,450.00%51K | 1,327.27%157K | 3,100.00%64K |
| Non-operating interest expense | 144.62%1.43M | 162.80%1.43M | 496.58%1.4M | 16,420.00%2.48M | 37,100.00%1.12M | 58,400.00%585K | 18,000.00%543K | 2,825.00%234K | 50.00%15K | 200.00%3K |
| Other net income (expense) | 226.32%24K | -100.03%-1K | -320.00%-21K | -55.60%226K | -7,252.38%-3.09M | 45.71%-19K | 449.92%3.34M | 76.19%-5K | 236.46%509K | 77.30%-42K |
| Special income (charges) | --0 | --0 | ---- | ---396K | ---3.09M | --0 | --2.69M | ---- | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | --396K | --3.09M | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | --0 | ---- | ---- | ---- | ---- | --2.69M | ---- | ---- | ---- |
| Other non- operating income (expenses) | 226.32%24K | -100.15%-1K | -320.00%-21K | 22.20%622K | --0 | 45.71%-19K | 6.43%646K | 76.19%-5K | 236.46%509K | 77.30%-42K |
| Income before tax | 6.59%-4.66M | -585.83%-6.54M | -29.97%-7.54M | 7.11%-21.28M | -61.26%-9.54M | 13.09%-4.99M | 82.20%-953K | 1.68%-5.8M | -54.60%-22.91M | -215.25%-5.91M |
| Income tax | 118.87%60K | -24.24%50K | 102.34%53K | -762.67%-2.43M | -42.38%87K | -736.00%-318K | -31.25%66K | -3,338.57%-2.27M | -3.42%367K | 12.69%151K |
| Net income | -1.05%-4.72M | -546.32%-6.59M | -114.89%-7.59M | 19.02%-18.85M | -58.68%-9.62M | 19.33%-4.68M | 81.30%-1.02M | 40.82%-3.53M | -53.14%-23.28M | -201.74%-6.07M |
| Net income continuous Operations | -1.05%-4.72M | -546.32%-6.59M | -114.89%-7.59M | 19.02%-18.85M | -58.68%-9.62M | 19.33%-4.68M | 81.30%-1.02M | 40.82%-3.53M | -53.14%-23.28M | -201.74%-6.07M |
| Minority interest income | 54.35%-21K | -20.00%-30K | 71.43%-14K | -45.74%-137K | -6.25%-17K | -48.39%-46K | -4.17%-25K | -113.04%-49K | -235.71%-94K | -128.57%-16K |
| Net income attributable to the parent company | -1.60%-4.7M | -559.56%-6.56M | -117.51%-7.58M | 19.28%-18.71M | -58.82%-9.61M | 19.69%-4.63M | 81.68%-994K | 41.41%-3.48M | -52.81%-23.18M | -202.00%-6.05M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -1.60%-4.7M | -559.56%-6.56M | -117.51%-7.58M | 19.28%-18.71M | -58.82%-9.61M | 19.69%-4.63M | 81.68%-994K | 41.41%-3.48M | -52.81%-23.18M | -202.00%-6.05M |
| Basic earnings per share | -7.69%-0.14 | -533.33%-0.19 | -120.00%-0.22 | 19.40%-0.54 | -64.71%-0.28 | 23.53%-0.13 | 81.25%-0.03 | 41.18%-0.1 | -52.27%-0.67 | -183.33%-0.17 |
| Diluted earnings per share | -7.69%-0.14 | -533.33%-0.19 | -120.00%-0.22 | 19.40%-0.54 | -64.71%-0.28 | 23.53%-0.13 | 81.25%-0.03 | 41.18%-0.1 | -52.27%-0.67 | -183.33%-0.17 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data